Eszter Erdei, Juan Toledo Marcos, Nikolett Varró, Kata Horváti, Bernadett Bacsa, István M. Mándity
{"title":"生物医学中的时空控制:光开关肽和折叠体。","authors":"Eszter Erdei, Juan Toledo Marcos, Nikolett Varró, Kata Horváti, Bernadett Bacsa, István M. Mándity","doi":"10.1111/bph.70163","DOIUrl":null,"url":null,"abstract":"<p>Photopharmacology integrates light-based technology with pharmacology to achieve precise control over biological processes, offering non-invasive activation and spatiotemporal regulation of biomolecular activity. Within this field, photoswitchable peptides and foldamers provide a powerful approach in precision medicine, enabling reversible conformational changes that toggle between active and inactive states. This light-driven modulation enhances targeted drug delivery, molecular sensing, and the development of photoresponsive biomaterials and optical devices. These dynamic systems hold immense potential for creating ‘smart’ therapeutics and biomaterials that adapt to environmental cues, revolutionizing biomedical applications. However, challenges persist in optimizing their stability, specificity and responsiveness in complex biological environments. Advances in light-responsive technologies and nanotechnology continue to push the boundaries of their applications, driving innovation in precision medicine and materials science. As research progresses, these systems are poised to transform drug delivery, diagnostics and next-generation biomaterials.</p>","PeriodicalId":9262,"journal":{"name":"British Journal of Pharmacology","volume":"182 19","pages":"4458-4465"},"PeriodicalIF":7.7000,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://bpspubs.onlinelibrary.wiley.com/doi/epdf/10.1111/bph.70163","citationCount":"0","resultStr":"{\"title\":\"Spatiotemporal control in biomedicine: photoswitchable peptides and foldamers\",\"authors\":\"Eszter Erdei, Juan Toledo Marcos, Nikolett Varró, Kata Horváti, Bernadett Bacsa, István M. Mándity\",\"doi\":\"10.1111/bph.70163\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Photopharmacology integrates light-based technology with pharmacology to achieve precise control over biological processes, offering non-invasive activation and spatiotemporal regulation of biomolecular activity. Within this field, photoswitchable peptides and foldamers provide a powerful approach in precision medicine, enabling reversible conformational changes that toggle between active and inactive states. This light-driven modulation enhances targeted drug delivery, molecular sensing, and the development of photoresponsive biomaterials and optical devices. These dynamic systems hold immense potential for creating ‘smart’ therapeutics and biomaterials that adapt to environmental cues, revolutionizing biomedical applications. However, challenges persist in optimizing their stability, specificity and responsiveness in complex biological environments. Advances in light-responsive technologies and nanotechnology continue to push the boundaries of their applications, driving innovation in precision medicine and materials science. As research progresses, these systems are poised to transform drug delivery, diagnostics and next-generation biomaterials.</p>\",\"PeriodicalId\":9262,\"journal\":{\"name\":\"British Journal of Pharmacology\",\"volume\":\"182 19\",\"pages\":\"4458-4465\"},\"PeriodicalIF\":7.7000,\"publicationDate\":\"2025-08-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://bpspubs.onlinelibrary.wiley.com/doi/epdf/10.1111/bph.70163\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British Journal of Pharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.70163\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.70163","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Spatiotemporal control in biomedicine: photoswitchable peptides and foldamers
Photopharmacology integrates light-based technology with pharmacology to achieve precise control over biological processes, offering non-invasive activation and spatiotemporal regulation of biomolecular activity. Within this field, photoswitchable peptides and foldamers provide a powerful approach in precision medicine, enabling reversible conformational changes that toggle between active and inactive states. This light-driven modulation enhances targeted drug delivery, molecular sensing, and the development of photoresponsive biomaterials and optical devices. These dynamic systems hold immense potential for creating ‘smart’ therapeutics and biomaterials that adapt to environmental cues, revolutionizing biomedical applications. However, challenges persist in optimizing their stability, specificity and responsiveness in complex biological environments. Advances in light-responsive technologies and nanotechnology continue to push the boundaries of their applications, driving innovation in precision medicine and materials science. As research progresses, these systems are poised to transform drug delivery, diagnostics and next-generation biomaterials.
期刊介绍:
The British Journal of Pharmacology (BJP) is a biomedical science journal offering comprehensive international coverage of experimental and translational pharmacology. It publishes original research, authoritative reviews, mini reviews, systematic reviews, meta-analyses, databases, letters to the Editor, and commentaries.
Review articles, databases, systematic reviews, and meta-analyses are typically commissioned, but unsolicited contributions are also considered, either as standalone papers or part of themed issues.
In addition to basic science research, BJP features translational pharmacology research, including proof-of-concept and early mechanistic studies in humans. While it generally does not publish first-in-man phase I studies or phase IIb, III, or IV studies, exceptions may be made under certain circumstances, particularly if results are combined with preclinical studies.